90 results
Page 3 of 5
8-K
EX-4.1
19b3u53q9leiyuf1r
18 Nov 16
Marina Biotech Announces Merger with IthenaPharma
12:00am
8-K
EX-4.1
gp9st f4si2rjs6uk9
22 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
2pegxeq b6
10 Aug 15
Marina Biotech’s CEQ508 Granted FDA Fast Track Designation
12:00am
8-K
EX-4.1
guj9vqson
11 Mar 14
Marina Biotech to use its RNAi, Antisense and microRNA Therapeutics Platform to Develop Drugs for Rare Diseases
12:00am
8-K
EX-4.1
nm6dkey5k
8 Aug 12
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry
12:00am
8-K
EX-4.1
mxz 7glk8o
20 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
h1u2sk3bd
13 Feb 12
Marina Biotech Announces Closing of $1.5 MM Bridge Loan
12:00am
8-K
EX-4.2
o4sz2fnvstrn1v
13 Feb 12
Marina Biotech Announces Closing of $1.5 MM Bridge Loan
12:00am
8-K
EX-4.2
segb7qim6zfn00
17 May 11
Marina Biotech Announces Proposed Public Offering of Common Stock and Warrants
12:00am
S-1/A
EX-4.14
4cmbrgpivvlhmec4
2 May 11
IPO registration (amended)
12:00am
S-1/A
EX-4.13
c27d3rtkhzc7cbz0r4c
2 May 11
IPO registration (amended)
12:00am
8-K
EX-4.2
6of935 a3
10 Feb 11
Marina Biotech Announces Pricing of Public Offering
12:00am
8-K
EX-4.1
xhfzhj72doq7lk9m
10 Feb 11
Marina Biotech Announces Pricing of Public Offering
12:00am
8-K
EX-4.2
i7n3slap62cbzw8bbmpy
5 Nov 10
Marina Biotech Announces Financing for up to $8.7 Million
12:00am
8-K
EX-4.1
j8cg7a6ym67gh90t
5 Nov 10
Marina Biotech Announces Financing for up to $8.7 Million
12:00am